BioCentury | Oct 24, 2019
Preclinical News
Oct. 24 Preclinical Quick Takes: anti-neuraminidase human antibodies for broad flu protection; plus Ionis-Baylor, Merck and more
...capable of inducing immunity across viral subtypes (see “The Universe of Universal Flu Vaccines” ). RICTOR-targeting...
...NASDAQ:IONS) and Baylor College of Medicine team has developed an antisense oligonucleotide (ASO) therapy against RICTOR...
...9; PTEN (MMAC1; TEP1) - Phosphatase and tensin homolog deleted on chromosome ten; RICTOR - Rapamycin-insensitive companion of mTOR...
...NASDAQ:IONS) and Baylor College of Medicine team has developed an antisense oligonucleotide (ASO) therapy against RICTOR...
...9; PTEN (MMAC1; TEP1) - Phosphatase and tensin homolog deleted on chromosome ten; RICTOR - Rapamycin-insensitive companion of mTOR...